Telogen effluvium: a sequela of COVID-19.
作者信息
Mieczkowska Karolina, Deutsch Alana, Borok Jenna, Guzman Anthony K, Fruchter Renee, Patel Parth, Wind Olivia, McLellan Beth N, Mann Ranon E, Halverstam Caroline P
机构信息
Department of Medicine, Division of Dermatology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA.
Division of Dermatology, Jacobi Medical Center, Bronx, NY, USA.
出版信息
Int J Dermatol. 2021 Jan;60(1):122-124. doi: 10.1111/ijd.15313. Epub 2020 Nov 23.
Abstract
摘要
相似文献
1
Telogen effluvium: a sequela of COVID-19.
Int J Dermatol. 2021 Jan;60(1):122-124. doi: 10.1111/ijd.15313. Epub 2020 Nov 23.
2
The Need to Analyze Telogen Effluvium and Alopecia Areata Parallelly in Long COVID Studies.
Influenza Other Respir Viruses. 2024 Jul;18(7):e13356. doi: 10.1111/irv.13356.
3
Red nail bands in conjunction with telogen effluvium as a post-COVID-19 phenomenon.
Australas J Dermatol. 2022 Feb;63(1):141-142. doi: 10.1111/ajd.13779. Epub 2021 Dec 27.
4
COVID-19: association with rapidly progressive forms of alopecia areata.
Int J Dermatol. 2021 Jan;60(1):127. doi: 10.1111/ijd.15317. Epub 2020 Nov 23.
5
Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity.
J Med Life. 2022 May;15(5):631-634. doi: 10.25122/jml-2021-0380.
6
Acute telogen effluvium associated with SARS-CoV-2 infection.
Aust J Gen Pract. 2020 Aug 26;49. doi: 10.31128/AJGP-COVID-32.
7
Time of onset and duration of post-COVID-19 acute telogen effluvium.
J Am Acad Dermatol. 2021 Oct;85(4):975-976. doi: 10.1016/j.jaad.2021.07.021. Epub 2021 Jul 21.
8
COVID-19 infection is a major cause of acute telogen effluvium.
Ir J Med Sci. 2022 Aug;191(4):1677-1681. doi: 10.1007/s11845-021-02754-5. Epub 2021 Aug 31.
9
Characteristics of telogen effluvium in COVID-19 in western Iran (2020).
An Bras Dermatol. 2021 Nov-Dec;96(6):688-692. doi: 10.1016/j.abd.2021.05.006. Epub 2021 Sep 15.
10
Early-onset effluvium secondary to COVID-19: Clinical and histologic characterization.
J Am Acad Dermatol. 2022 May;86(5):e207-e208. doi: 10.1016/j.jaad.2021.09.072. Epub 2021 Dec 11.
引用本文的文献
1
Telogen Effluvium Following Coronavirus Disease-2019 Infection: A Retrospective Study of 113 Cases.
Int J Trichology. 2025 Jan-Feb;17(1):32-35. doi: 10.4103/ijt.ijt_38_22. Epub 2025 Jun 23.
2
Outcomes in Patients with Long COVID-19 One Year After their Discharge from Intensive Care Units.
Cureus. 2025 Apr 5;17(4):e81739. doi: 10.7759/cureus.81739. eCollection 2025 Apr.
3
Asymptomatic SARS-COV2 Infection or COVID-19 vaccination effect for severe multisystem inflammatory syndrome in a 6-year-old girl: case report and review of the literature.
Ital J Pediatr. 2024 Sep 27;50(1):194. doi: 10.1186/s13052-024-01758-y.
4
Persistence of long COVID symptoms in COVID-19 survivors worldwide and its potential pathogenesis - A systematic review and meta-analysis.
Narra J. 2021 Aug;1(2):e36. doi: 10.52225/narraj.v1i2.36. Epub 2021 Aug 1.
5
A Cross-Sectional Study on Post-Coronavirus Disease (COVID-19) Hair Loss at a Tertiary Care Hospital.
Dermatol Pract Concept. 2023 Oct 1;13(4):e2023263. doi: 10.5826/dpc.1304a263.
6
TCM "medicine and food homology" in the management of post-COVID disorders.
Front Immunol. 2023 Aug 31;14:1234307. doi: 10.3389/fimmu.2023.1234307. eCollection 2023.
7
[Review of the post-COVID-19 syndrome associated to acute telogen effluvium].
Rev Med Inst Mex Seguro Soc. 2023 Jul 31;61(4):496-501. doi: 10.5281/zenodo.8200471.
8
Effects of official information and rumor on resource-epidemic coevolution dynamics.
J King Saud Univ Comput Inf Sci. 2022 Nov;34(10):9207-9215. doi: 10.1016/j.jksuci.2022.09.003. Epub 2022 Sep 8.
9
Post COVID-19 syndrome and new onset diseases: a prospective observational study.
Singapore Med J. 2025 Jul 1;66(7):354-361. doi: 10.4103/singaporemedj.SMJ-2022-055. Epub 2023 Apr 7.
10
The Effect of Covid-19 on the Hair Diseases Observed in Health Care Providers: Analysis of 513 Participants.
Dermatol Pract Concept. 2023 Jan 1;13(1):e2023036. doi: 10.5826/dpc.1301a36.
本文引用的文献
1
A Review of the Dermatological Manifestations of Coronavirus Disease 2019 (COVID-19).
Dermatol Res Pract. 2020 Aug 11;2020:9360476. doi: 10.1155/2020/9360476. eCollection 2020.
2
Telogen Effluvium: A Review of the Literature.
Cureus. 2020 May 27;12(5):e8320. doi: 10.7759/cureus.8320.
3
Evaluation of the effects of COVID-19 pandemic on hair diseases through a web-based questionnaire.
Dermatol Ther. 2020 Nov;33(6):e13923. doi: 10.1111/dth.13923. Epub 2020 Jul 16.
4
COVID-19 Pandemic: Cardiovascular Complications and Future Implications.
Am J Cardiovasc Drugs. 2020 Aug;20(4):311-324. doi: 10.1007/s40256-020-00420-2.
5
Management of telogen effluvium during the COVID-19 emergency: Psychological implications.
Dermatol Ther. 2020 Jul;33(4):e13648. doi: 10.1111/dth.13648. Epub 2020 Jun 5.
6
Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review.
Int J Womens Dermatol. 2018 Jun 19;4(4):203-211. doi: 10.1016/j.ijwd.2018.05.001. eCollection 2018 Dec.
Zotero 插件